Veru (VERU) 10-K 2 Dec 15 2015 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2015	Nov. 27, 2015	Mar. 31, 2015
Document And Entity Information [Abstract]
Document Type	10-K
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Entity Registrant Name	FEMALE HEALTH CO
Entity Central Index Key	863,894
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	--09-30
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Public Float			$ 75
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Common Stock, Shares Outstanding		29,023,832

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Sep. 30, 2014
Current Assets:
Cash	$ 4,105,814	$ 5,796,223
Accounts receivable, net of allowance for doubtful accountis of $48,068 for 2015 and 2014	14,088,390	2,943,850
Income tax receivable	21,251
Inventory, net	1,745,180	2,983,447
Prepaid expenses and other current assets	609,320	638,243
Deferred income taxes	1,016,000	711,000
TOTAL CURRENT ASSETS	21,585,955	13,072,763
Other assets	136,766	166,084
PLANT AND EQUIPMENT
Equipment, furniture and fixtures	4,680,246	4,590,124
Leasehold improvements	323,147	323,147
Less accumulated depreciation and amortization	(3,763,403)	(3,310,964)
Plant and equipment, net	1,239,990	1,602,307
Deferred income taxes	14,509,000	16,832,000
TOTAL ASSETS	37,471,711	31,673,154
Current liabilities:
Accounts payable	1,077,349	1,124,859
Accrued expenses and other current liabilities	2,555,231	1,816,508
Accrued compensation	592,428	436,843
TOTAL CURRENT LIABILITIES	4,225,008	3,378,210
Long-term liabilities:
Deferred rent	15,389	39,105
Deferred income taxes	98,252	190,513
TOTAL LIABILITIES	$ 4,338,649	$ 3,607,828
Commitments and Contingencies
STOCKHOLDERS' EQUITY:
Preferred stock; no shares issued and outstanding in 2015 or 2014
Common stock, par value $0.01 per share; authorized 38,500,000 shares; issued 31,192,536 and 30,958,669, and 29,008,832 and 28,775,215 shares outstanding in 2015 and 2014 respectively	$ 311,925	$ 309,587
Additional paid-in-capital	69,205,201	68,484,889
Accumulated other comprehensive loss	(581,519)	(581,519)
Accumulated deficit	(27,995,940)	(32,341,976)
Treasury stock, at cost	(7,806,605)	(7,805,655)
TOTAL STOCKHOLDERS' EQUITY	33,133,062	28,065,326
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 37,471,711	$ 31,673,154

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2015	Sep. 30, 2014
Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 48,068	$ 48,068
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common Stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized	38,500,000	38,500,000
Common Stock, shares issued	31,192,536	30,958,669
Common Stock, shares outstanding	29,008,832	28,775,215

Consolidated Statements Of Inco

Consolidated Statements Of Income - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Consolidated Statements Of Income [Abstract]
Net revenues	$ 32,604,865	$ 24,490,586	$ 31,456,778
Cost of sales	13,634,906	11,369,108	13,952,420
Gross profit	18,969,959	13,121,478	17,504,358
Operating expenses:
Research and development	219,815	5,575	4,745
Advertising	0	58,121	221,718
Selling, general and administrative	12,131,737	9,133,870	7,488,298
Total operating expenses	12,351,552	9,197,566	7,714,761
Operating income	6,618,407	3,923,912	9,789,597
Non-operating income:
Interest and other income, net	10,150	117,123	245,545
Foreign currency transaction gain (loss)	58,483	(83,844)	(101,288)
Total non-operating income	68,633	33,279	144,257
Income before income taxes	6,687,040	3,957,191	9,933,854
Income tax expense (benefit)	2,341,004	1,524,130	(4,408,744)
Net income	$ 4,346,036	$ 2,433,061	$ 14,342,598
Net income per basic common share outstanding (in Dollars per share)	$ 0.15	$ 0.09	$ 0.51
Basic weighted average common shares outstanding (in Shares)	28,532,327	28,522,525	28,376,607
Net income per diluted common share outstanding (in Dollars per share)	$ 0.15	$ 0.08	$ 0.50
Diluted weighted average common shares outstanding (in Shares)	28,917,048	28,865,384	28,726,478
Cash dividends declared per common share (in Dollars per share)		$ 0.21	$ 0.26

Consolidated Statements Of Stoc

Consolidated Statements Of Stockholders’ Equity - USD ($)	Common Stock [Member]Cashless [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]Cashless [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Treasury Stock at Cost [Member]	Total
Balance at Sep. 30, 2012		$ 305,500		$ 66,760,907	$ (581,519)	$ (35,594,455)	$ (6,672,243)	$ 24,218,190
Balance (in Shares) at Sep. 30, 2012		30,550,030
Share-based compensation		$ 731		700,288				$ 701,019
Share-based compensation (in Shares)		73,176
Issuance of common stock upon cashless exercise of warrants	$ 435		$ (435)
Issuance of common stock upon cashless exercise of warrants (in Shares)	43,465
Issuance of common stock upon cashless exercise of options	$ 282		(282)
Issuance of common stock upon cashless exercise of options (in Shares)	28,172							28,172
Stock repurchase – Total							(395,667)	$ (395,667)
Common stock dividends						(7,463,183)		(7,463,183)
Net income and comprehensive income						14,342,598		14,342,598
Balance at Sep. 30, 2013		$ 306,948		67,460,478	(581,519)	(28,715,040)	(7,067,910)	31,402,957
Balance (in Shares) at Sep. 30, 2013		30,694,843
Share-based compensation		$ 2,169		907,281				909,450
Share-based compensation (in Shares)		216,863
Issuance of common stock upon cash exercise of options		$ 300		117,300				$ 117,600
Issuance of common stock upon cash exercise of options (in Shares)		30,000
Issuance of common stock upon cashless exercise of options	$ 170		$ (170)
Issuance of common stock upon cashless exercise of options (in Shares)	16,963							16,963
Stock repurchase – Total							(737,745)	$ (737,745)
Common stock dividends						(6,059,997)		(6,059,997)
Net income and comprehensive income						2,433,061		2,433,061
Balance at Sep. 30, 2014		$ 309,587		68,484,889	(581,519)	(32,341,976)	(7,805,655)	28,065,326
Balance (in Shares) at Sep. 30, 2014		30,958,669
Share-based compensation		$ 2,338		720,312				722,650
Share-based compensation (in Shares)		233,867
Stock repurchase – Total							(950)	(950)
Net income and comprehensive income						4,346,036		4,346,036
Balance at Sep. 30, 2015		$ 311,925		$ 69,205,201	$ (581,519)	$ (27,995,940)	$ (7,806,605)	$ 33,133,062
Balance (in Shares) at Sep. 30, 2015		31,192,536

Consolidated Statements Of Sto6

Consolidated Statements Of Stockholders’ Equity (Parenthetical) - shares	12 Months Ended			72 Months Ended	105 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2015
Issuance of common stock upon cashless exercise of options		16,963	28,172
Cashless options, exercises in period		30,000	36,250
Treasury shares	250	169,000	55,625	1,958,829	2,183,704
Cashless [Member]
Warrants, exercises in period			52,000
Cashless options, exercises in period		30,000	36,250
Common Stock [Member]
Issuance of common stock upon exercise of options		30,000
Common Stock [Member] | Cashless [Member]
Issuance of common stock upon cashless exercise of warrants			43,465
Issuance of common stock upon cashless exercise of options		16,963	28,172

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
OPERATING ACTIVITIES
Net income	$ 4,346,036	$ 2,433,061	$ 14,342,598
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	494,258	589,343	556,304
Provision for obsolete inventory	173,634	37,603	(6,662)
Provision for bad debts		38,068	3,180
Share-based compensation	489,689	858,615	727,609
Deferred income taxes	1,925,739	1,012,334	(5,259,065)
Loss on disposal of fixed assets	3,483	491	940
Changes in operating assets and liabilities:
Accounts receivable	(11,144,540)	(619,753)	4,903,572
Income tax receivable	(21,251)	78,440	(51,071)
Inventories	1,064,633	(561,633)	(994,556)
Prepaid expenses and other assets	58,241	(151,656)	93,933
Accounts payable	(47,510)	220,810	(871,278)
Accrued expenses and other current liabilities	1,108,891	(270,310)	(1,652,423)
Net cash (used in) provided by operating activities	(1,548,697)	3,665,413	11,793,081
INVESTING ACTIVITIES
Capital expenditures	(135,424)	(97,311)	(302,198)
Net cash used in investing activities	(135,424)	(97,311)	(302,198)
FINANCING ACTIVITIES
Proceeds from exercise of stock options		117,600
Purchases of common stock for treasury shares	(950)	(737,745)	(395,667)
Dividends paid on common stock	(5,338)	(6,074,164)	(7,468,248)
Net cash used in financing activities	(6,288)	(6,694,309)	(7,863,915)
Net (decrease) increase in cash	(1,690,409)	(3,126,207)	3,626,968
Cash at beginning of period	5,796,223	8,922,430	5,295,462
CASH AT END OF YEAR	4,105,814	5,796,223	8,922,430
Supplemental Disclosure of Cash Flow Information:
Cash payments for income taxes	294,441	773,041	345,657
Schedule of noncash financing and investing activities:
Dividends payable		6,913	12,530
Reduction of accrued expense upon issuance of shares	$ 255,577	$ 311,515	$ 200,088

Nature of Business and Signific

Nature of Business and Significant Accounting Policies	12 Months Ended
	Sep. 30, 2015
Nature of Business and Significant Accounting Policies [Abstract]
Nature of Business and Significant Accounting Policies	Note 1. Nature of Business and Significant Accounting Policies Principles of consolidation and nature of operations : The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, The Female Health Company – UK, and its wholly owned subsidiaries, The Female Health Company - UK, plc and The Female Health Company (M) SDN.BHD. All significant intercompany transactions and accounts have been eliminated in consolidati on. The Female Health Company ( FHC or the Company) is currently engaged in the marketing, manufacture and distribution of a consumer health care product, the FC2 female condom ( FC2). The Female Health Company - UK, is the holding company of The Female Health Company - UK, plc, which is located in a 6,400 sq. ft. leased office facility located in London, England (collectively the U.K. subsidiary) . The Female Health Company (M) SDN.BHD leases a 45,800 sq. ft. manufacturing facility located in Selangor D.E., Malaysia (the Malaysia subsidiary) . FC2 has been distributed in either or both commercial (private sector) and public health sector markets in 144 countries. It is marketed to consumers through distributors, public health programs and retailers in 16 countries. The Company's standard credit terms vary from 30 to 120 days, depending on the class of trade and customary terms within a territory, so accounts receivable is affected by the mix of purchasers within the period. As is typical in the Company's business, extended credit terms may occasionally be offered as a sales promotion or for certain sales . The Company has agreed to credit terms of up to 150 days with our distributor in the Republic of South Africa. For the most recent order of 15 million units under the Brazil tender, the Company has agreed to up to 360 day credit terms with our distributor in Brazil subject to earlier payment upon receipt of payment by the distributor from the Brazilian Government. For the past twelve months, the Company's average days’ sales outstanding was approximately 131 days. Over the past five years, the Company’s bad debt expense has been less than 0.03 percent of product sales. Use of estimates : The preparation of financial statements requires management to make estimates and use assumptions that affect certain reported amounts and disclosures. Significant accounting estimates include the deferred income tax valuation allowance and the value of share -based compensation. Actual results may differ from those estimates. Cash concentration : The Company’s cash is maintained primarily in three financial institutions, located in Clayton, Missouri, London, England and Kuala Lumpur, Malaysia , respectively . Accounts receivable and concentration of credit risk : Accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a periodic basis. The components of accounts receivable consist of the following at September 30, 2015 and 2014 : 2015 2014 Trade receivables $ $ Other receivables Accounts receivable, gross Less: allowance for doubtful accounts Accounts receivable, net $ $ The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments on accounts receivable. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Management also periodically evaluates individual customer receivables and considers a customer’s financial condition, credit history, and the current economic conditions. Accounts receivable are written-off when deemed uncollectible. The table below sets forth the components of the allowance for doubtful accounts for the years ended September 30: Balance at Provision Charges Write offs/ Balance at Year October 1 to Expenses Recoveries September 30 2013 $ $ $ $ 2014 $ $ $ $ 2015 $ $ — $ — $ Recoveries of accounts receivable previously written-off are recorded when received. The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other governmental agencies which purchase and distribute the female condom for use in HIV/AIDS prevention and family planning programs. In fiscal year 201 5 , our significant customers were Sem ina Indústria e Comércio Ltda ( Semina), U nited Nations Population Fund ( UNFPA), and John Snow, Inc., facilitat or of USAID I DELIVER project ( USAID) . In fiscal year 2014, our significant customers were UNFPA, USAID, Sekunjalo Inve stments Corporation (PTY) Ltd ( Sekunjalo) , and Azinor International Lda ( Azinor). In fiscal year 2013, our significant customer was UNFPA. No other single customer accounted for more than 10 percent of unit sales during those periods. Percentage of Unit Sales Significant Customers 2015 2014 2013 Semina * * UNFPA USAID * Sekunjalo * * Azinor * * Total Percentage of Unit Sales _____________________ * Less than 10 percent of unit sales. Semina’s accounts receivable balance represented 46 percent of current assets at September 30, 2015 and UNFPA’s accounts receivable balance represented 12 percent of current assets at September 30, 2014. No other single customer’s accounts receivable balance accounted for more than 10 percent of current assets at the end of those periods. Inventory : Inventories are valued at the lower of cost or market. The cost is determined using the first-in, first-out (FIFO) method. Inventories are also written down for management’s estimates of product which will not sell prior to its expiration date. Write-downs of inventories establish a new cost basis which is not increased for future increases in the market value of inventories or changes in estimated obsolescence. Foreign currency translation and operations : Effective October 1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries’ functional currency. The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries. Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company’s first generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October 1, 2009. As the Malaysia subsid iary is a direct and integral component of the U.K. parent’s operations, it, too, adopted the U.S. dollar as its functional currency as of October 1, 2009. The consistent use of the U.S. dollar as functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The Company recognized a foreign currency transaction gain of $ 58,483 and a foreign currency transaction loss of $ 83,844 and $ 101,288 for the years ended September 30, 2015, 2014, and 2013 , respectively. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was $581,519 as of September 30, 2015 and 2014 . Assets located outside of the U.S. totaled approximately $10,000,000 and $12,000,000 at September 30, 2015 and 2014 , respectively. Equipment, furniture and fixtures : Depreciation and amortization are computed using primarily the straight-line method. Depreciation and amortization are computed over the estimated useful lives of the respective assets which range as follows: Manufacturing equipment 5 – 10 years Office equipment 3 years Furniture and fixtures 7 – 10 years Depreciation on leased assets is computed over the lesser of the remaining lease term or the estimated useful lives of the assets. Depreciation on leased assets is included with depreciation on owned assets. Patents and trademarks : The costs for patents and trademarks are expensed when incurred. FC2 patents have been issued by the United States, Europe, Canada, Australia, South Africa, the People’s Republic of China, Japan, Mexico, Brazil, India and the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, Gambia, Ghana , Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone, Sudan, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. Further, the European patent for FC2 has been validated in the following countries: Austria, Belgium, Bulgaria, Switzerland, Republic of Cyprus, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, United Kingdom, Greece, Hungary, Ireland, Italy, Luxembourg, Monaco, Netherlands, Portugal, Romania, Sweden, Slovenia, Slovakia, and Turkey. The patents cover the key aspects of FC2, including its overall design and manufacturing process. The patents have expiration dates in 2023 and 2024. In addition, patent applications for FC2 are pending in a number of other countries around the world. There can be no assurance that pending patent applications provide the Company with protection against copycat products entering markets during the pendency of the applications. The Company has a registration for the trademark “FC2 Female Condom” in the United States. Furthermore, the Company has filed applications or secured registrations in 39 countries or jurisdictions around the world to protect the various names and symbols used in marketing FC2. In addition, the experience that has been gained through years of manufacturing its Female Condoms (FC1 and FC2) has allowed the Company to develop trade secrets and know-how, including certain proprietary production technologies, that further protect its competitive position. Financial instruments : The Company follows ASC Topic 820, Fair Value Measurements and Disclosures , which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The Company currently does not have any assets or liabilities measured at fair value on a recurring or non-recurring basis. Substantially all of the Company’s cash , as well as restricted cash , are held in demand deposits with three financial institutions. The Company has no financial instruments for which the carrying value is materially different than fair value. Research and development costs : Research and development costs are expensed as incurred. The amount of costs expensed for the years ended September 30, 2015, 2014, and 2013 were $219,815 , $5,575 , and $4,745 , respectively . Restricted cash : Restricted cash relates to security provided to one of the Company’s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of $250,000 for such performance bonds. Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provi der of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiratio n of the product shelf life. Restricted cash was $85,697 and $55,806 for the years ended September 30, 2015 and 2014 , respectively, and is included in cash on the accompanying balance sheets. Revenue recognition : The Company recognizes revenue from product sales when each of the following conditions has been met: an arrangement exists, delivery has occurred, there is a fixed price, and collectability is reasonably assured. Share-based compensation : The Company accounts for stock-based compensation expense for equity awards exchanged for services over the vesting period base d on the grant-date fair value. In many instances, the equity awards are issued upon the grant date subject to vesting periods. In certain instances, the equity awards provide for future issuance contingent on future continued employ ment or performance of services as of the issuance date. Advertising : The Company's policy is to expense advertising costs as incurred. Advertising costs were $ 0 , $ 58,121 , and $ 221,718 for the years ended September 30, 2015, 2014, and 2013 , respectively. Income taxes : The Company files separate income tax returns for its foreign subsidiaries. ASC Topic 740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized. Earnings per share (EPS) : Basic EPS is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options and unvested shares granted to employees and directors. Other comprehensive income : Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net income. Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying consolidated balance sheets, these items, along with net income, are components of comprehensive income. The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company’s policy and intent is to settle the intercompany trade account on a current basis. Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October 1, 2009, no foreign currency gains or losses from intercompany trade are recognized. In fiscal 2015, 2014, and 2013 , comprehensive income is equivalent to the reported net income. Reclassifications: Certain items in the 2014 and 2013 consolidated financial statements have been reclassified to conform to the 2015 presentation.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share	Note 2. Earnings per Share Basic EPS is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options and unvested shares granted to employees and directors . Year Ended September 30, Denominator 2015 2014 2013 Weighted average common shares outstanding - basic Net effect of dilutive securities: Options Unvested restricted shares Total net effect of dilutive securities Weighted average common shares outstanding - diluted Income per common share – basic $ $ $ Income per common share – diluted $ $ $ Options to purchase approximately 90,000 shares of common stock at an exercise price of $3.92 per share that were outstanding for the year end September 30, 2015, were not included in the computation of diluted net income per share because their effect was anti-dilutive. All other outstanding stock options were included in the computation of diluted net income per share for the years ended September 30, 2015, 2014, and 2013 .

Inventory

Inventory	12 Months Ended
	Sep. 30, 2015
Inventory [Abstract]
Inventory	Note 3. Inventory The components of inventory consist of the following at September 30, 2015 and 2014 : 2015 2014 Raw material $ $ Work in process Finished goods Inventory, gross Less: inventory reserves Inventory, net $ $ The change in the inventory reserve for the years ended September 30 is as follows: Balance at Charged to Costs Balance at Year October 1 and Expenses Write-offs September 30 2013 $ $ $ $ 2014 $ $ $ $ 2015 $ $ $ $

Revolving Line Of Credit

Revolving Line Of Credit	12 Months Ended
	Sep. 30, 2015
Revolving Line Of Credit [Abstract]
Revolving Line Of Credit	Note 4. Revolving Line of Credit On August 1, 201 5 , the Company entered into an amendment to the Second Amended and Restated Loan Agreement (as amended, the “Loan Agreement”) with Midland States Bank to extend the term of the Company’s revolving line of credit to August 1, 201 6 . The credit facility consists of a single revolving note for up to $2 million with Midland States Bank, with borrowings limited to a borrowing base determined based on 70 percent to 80 percent of eligible accounts receivable plus 50 percent of eligible inventory. Significant restrictive covenants in the Loan Agreement include prohibitions on any merger, consolidation or sale of all or a substantial portion of the Company’s assets and limits on the payment of dividends or the repurchase of shares. The Loan Agreement does not contain any financial covenants that require compliance with ratios or amounts. Dividends and share repurchases are permitted as long as after giving effect to the dividend or share repurchase the Company has a ratio of total liabilities to total stockholders’ equity of no more than 1 :1 . Borrowings on the revolving note bear interest at the national prime rate published by the Wall Street Journal ( 3.25 percent at September 30, 2015 ). The note is collateralized by substantially all of the assets of the Company. No amounts were outstanding under the revolving note at either September 30, 2015 or 2014 .

Operating Leases And Rental Exp

Operating Leases And Rental Expense	12 Months Ended
	Sep. 30, 2015
Operating Leases And Rental Expense [Abstract]
Operating Leases And Rental Expense	Note 5 . Operating Leases and Rental Expense The Company’s corporate headquarters is located in approximately 5,100 square feet of office space located in Chicago, Illinois. On March 10, 2011, the Company signed a lease amendment, effective November 1, 2010, which extended the lease term for this office space for a five year period commencing on November 1, 2011 and ending on October 31, 2016. The lease amendment grants the Company a five month lease abatement beginning November 1, 2010, reduces base rent and provides a tenant improvement allowance. The lease requires escalating monthly payments ranging from $6,797 to $7,859 , plus real estate taxes, utilities and maintenance expenses from April 1, 2011 to October 31, 2016. The Company has delivered notice of its intent to extend the term of the lease for an additional three year period ending October 31, 2019. The Company has the right to rescind such lease extension upon receipt of the landlord’s notice of the new base rent for the extended term. The Company leases 6,400 square feet of office space located in London, England. The lease expires in June 2020 . The lease require s quarterly payments of approximately $13,500 through December 2011 and quarterly payments of approximately $27,000 from January 2012 through June 2015. The lease stipulate d that after 5 years (June 2015) the principal rent will be reviewed and adjusted to the higher of the principal rent immediately prior to the review date or the market rate. As of September 30, 2015, the lease has not been reviewed or adjusted and quarterly payments of approximately $27,000 will continue. Based on the terms of the lease agreement, the Company was also required to make a security deposit equivalent to six months’ rent (approximately $ 67,000 ). The Company leases 45,800 square feet of manufacturing space in Selangor D.E., Malaysia under a lease that requires monthly payments of approximately $13,000 through September 2016 and may be renewed at the option of the Company for an additional three year term. The Company also leases equipment under a number of lease agreements which expire at various dates through June 2020 . The aggregate monthly rental was $ 616 at September 30, 2015 . Details of operating lease expense, including real estate taxes and insurance, for the years ended September 30, 2015, 2014, and 2013 are as follows: 2015 2014 2013 Factory and office leases $ $ $ Other Total $ $ $ Future minimum payments under leases consist of the following as of September 30, 2015 : Operating Leases 2016 2017 2018 2019 2020 Total minimum lease payments $

Income Taxes

Income Taxes	12 Months Ended
	Sep. 30, 2015
Income Taxes [Abstract]
Income Taxes	Note 6. Income Taxes The Company accounts for income taxes using the liability method, which requires the recognition of deferred tax assets or liabilities for the tax-effected temporary differences between the financial reporting and tax bases of assets and liabilities, and for net operating loss and tax credit carryforwards. The Company completes a detailed analysis of its deferred income tax valuation allowance on an annual basis or more frequently if information comes to our attention that would indicate that a revision to its estimates is necessary. In evaluating the Company’s ability to realize its deferred tax assets, management considers all available positive and negative evidence on a country by country basis, including past operating results and forecast of future taxable income. In determining future taxable income, management makes assumptions to forecast U.S. federal and state, U.K. and Malaysia operating income, the reversal of temporary differences, and the implementation of any feasible and prudent tax planning strategies. These assumptions require significant judgment regarding the forecasts of the future taxable income in each tax jurisdiction, and are consistent with the forecasts used to manage the Company’s business. It should be noted that the Company realized significant losses through 2005 on a consolidated basis. Since fiscal year 2006, the Company has consistently generated taxable income on a consolidated basis, providing a reasonable future period in which the Company can reasonably expect to generate taxable income. In management’s analysis to determine the amount of the deferred tax asset to recognize, management projected future taxable income for each tax jurisdiction. Although management uses the best information available, it is reasonably possible that the estimates used by the Company will be materially different from the actual results. These differences could have a material effect on the Company's future results of operations and financial condition. Income before income taxes was taxed by the following jurisdictions for the years ended September 30, 2015, 2014, and 2013 : 2015 2014 2013 Domestic $ $ $ Foreign Total $ $ $ A reconciliation of income tax expense ( benefit) and the amount computed by applying the statutory Federal income tax rate to income before income taxes for the years ended September 30, 2015, 2014, and 2013 is as follows: 2015 2014 2013 Income tax expense at statutory rates $ $ $ State income tax, net of federal benefits Non-deductible expenses Effect of lower foreign income tax rates Effect of change in U.K. tax rate — — Effect of reinvestment allowance - Malaysia — Effect of export allowance - Malaysia — — Effect of change in Illinois tax rate — — Effect of conversion of charitable contribution to NOL — — Other — Change in valuation allowance Income tax expense (benefit) $ $ $ As of September 30, 2015 , the Company had federal and state net operating loss carryforwards of approximately $ 13,023,000 and $ 12,587,000 , respectively, for income tax purposes expiring in years 20 20 to 2027. The Company's U.K. subsidiary has U.K. net operating loss carryforwards of approximately $ 61,938,000 as of September 30, 2015 , which can be carried forward indefinitely to be used to offset future U.K. taxable income. The federal and state income tax expense (benefit) for the years ended September 30, 2015, 2014, and 2013 is summarized below: 2015 2014 2013 Deferred – U.S. $ $ $ Deferred – U.K. Deferred – Malaysia Subtotal Current – U.S. Current – Malaysia Current - U.K. — — Subtotal Income tax expense (benefit) $ $ $ Significant components of the Company's deferred tax assets and liabilities are as follows at September 30, 2015 and 2014 : Deferred Tax Assets 2015 2014 Federal net operating loss carryforwards $ $ State net operating loss carryforwards AMT credit carryforward Foreign net operating loss carryforwards – U.K. Foreign capital allowance – U.K. Other, net - Malaysia Share-based compensation Other, net - U.S. Gross deferred tax assets Valuation allowance for deferred tax assets Net deferred tax assets Deferred Tax Liabilities: Foreign capital allowance – Malaysia Net deferred tax assets $ $ The deferred tax amounts have been classified in the accompanying consolidated balance sheets at September 30 as follows: 2015 2014 Current assets – U.S. $ $ Current assets – U.K. — Total current assets Long-term assets – U.S. Long-term assets – U.K Total long-term assets Long-term liability – Malaysia $ $ The change in the valuation allowance for deferred tax assets for the years ended September 30 is as follows: Balance at Charged to Costs Balance at Year October 1 and Expenses Deductions/Other September 30 2013 $ $ $ $ 2014 $ $ $ $ 2015 $ $ $ — $ The valuation allowance de creased by $ 16,000 , increased by $ 444,000 , and decreased by $ 10,453,000 for the years ended September 30, 2015, 2014, and 2013 , respectively. Under the Internal Revenue Code, certain ownership changes, including the prior issuance of preferred stock, the public offering of common stock and the exercise of common stock warrants and options may subject the Company to annual limitations on the utilization of its net operating loss carryforward. Under the Inland Revenue statutes, certain triggering events may subject the Company to limitations on the utilization of its net operating loss carryforward in the U.K. As of September 30, 2015 , management does not believe any limitations have occurred. The Company has not recorded deferred income taxes applicable to undistributed earnings of foreign subsidiaries because it is the present intention of management to reinvest the undistributed earning indefinitely. Generally such earnings become subject to U.S. tax upon remittance of dividends and under certain other circumstances. It is not practicable to estimate the amount of deferred tax or such undistributed earnings. ASC Topic 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 developed a two-step process to evaluate a tax position and also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has not recorded a reserve for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company files tax returns in all appropriate jurisdictions, including foreign, U.S. Federal and Illinois and Virginia State tax returns. The following summarizes open tax years in the relevant jurisdictions: · For the U.S., a tax return may be audited any time within 3 years from filing date. The U.S. open tax years are for fiscal years 2012 through 2014, which expire in years 2016 through 2018, respectively. · For Malaysia, a tax return may be audited any time within 5 years from filing date ( 7 months after the fiscal year end). The Malaysia open tax years are for 2010 through 2014, which expire on December 31, 2015 through 2019. · For the U.K., a tax return may be audited within 1 year from the later of: the filing date or the filing deadline ( 1 year after the end of the accounting period). T he U.K. open tax year is for 201 4, which expires in 2016 . The fiscal year 2015 tax returns for each jurisdiction have not been filed as of the date of this filing. As of September 30, 2015 and 2014 , the Company has no recorded liability for unrecognized tax benefits. The Company recognizes interest and penalties related to uncertain tax positions as income tax expense as incurred. No expense for interest and penalties was recognized for the years ended September 30, 2015, 2014, and 2013 .

Equity And Share-Based Payments

Equity And Share-Based Payments	12 Months Ended
	Sep. 30, 2015
Equity And Share-Based Payments [Abstract]
Equity And Share-Based Payments	Note 7. Equity and Share-based Payments In March 2008, the Company’s shareholders approved the 2008 Stock Incentive Plan which is utilized to provide equity opportunities and performance–based incentives to attract, retain and motivate those persons who make (or are expected to make) important contributions to the Company. A total of 2 million shares are available for issuance under the plan. As of September 30, 2015 , a total of 1,287,885 shares have been granted under the plan, of which 150,000 shares were in the form of stock options and the remainder were in the form of restricted stock or other share grants. Stock Option Plans Under the Company’s previous share-based long-term incentive compensation plan, the 1997 Stock Option Plan, the Company granted non-qualified stock options to employees. There are no shares available for grant under this plan which expired on December 31, 2006 . Options issued under this plan expire 10 years after the date of grant and generally vested 1/36 per month, with full vesting after three years. Under the Company’s 2008 Stock Incentive Plan, options issued expire 10 years after the date of grant and vest 1/36 per month, with full vesting after three years. The Company did not grant any options during the years ended September 30, 2015 , 2014, and 2013 . Compensation expense is recognized only for share-based payments expected to vest. The Company estimates forfeitures at the date of grant based on historical experience and future expectations. There was no s tock compensation expense related to options for the years ended September 30, 2015, 2014, and 2013 . Option Activity The following table summarizes the stock options outstanding and exercisable at September 30, 2015 : Weighted Average Remaining Aggregate Exercise Price Contractual Term Intrinsic Shares Per Share (years) Value Outstanding at September 30, 2012 $ Granted — - Exercised Forfeited — - Outstanding at September 30, 2013 $ Granted — — Exercised Forfeited — — Outstanding at September 30, 2014 $ Granted — — Exercised — — Forfeited — — Outstanding at September 30, 2015 $ $ Exercisable on September 30, 2015 $ $ No stock options were exercised during the year ended September 30, 2015 . During the year ended September 30, 2014 , stock option holders exercised 60,000 stock options, 30,000 shares using the cashless exercise option available under the plan which entitled them to 16,963 shares of common stock and 30,000 shares using the cash exercise option available under the plan resulting in cash proceeds of $117,600 . During the year ended September 30, 2013 , stock option holders exercised 36,250 stock options, using the cashless exercise option available under the plan which entitled them to 28,172 shares of common stock. The aggregate intrinsic value in the table above is before income taxes, based on the Company’s closing stock price of $ 1.58 on the last day of business for the period ended September 30, 2015 . The total intrinsic value of options e xercised during the years ended September 30, 2015, 2014, and 2013 , was approx imately $0, $154,000 and $272,000 , respectively. Restricted Stock The Company issues restricted stock to employees, directors and consultants. Such issuances may have vesting periods that range from one to three years. In addition, the Company has issued stock awards to certain employees and directors that provide for future issuance contingent on continued employment or performance of services for p eriods that range from one to three years. A summary of the non-vested stock activity for fiscal years 2015, 2014, and 2013 is summarized in the table below: Weighted Average Grant -Date Shares Fair Value Vesting Period Total Outstanding September 30, 2012 $ Stock Granted September 2013 - May 2016 Vested Forfeited Total Outstanding September 30, 2013 $ Stock Granted September 2014 - December 2016 Vested Forfeited Total Outstanding September 30, 2014 $ Stock Granted September 2015 - August 2018 Vested Forfeited Total Outstanding September 30, 2015 $ The Company granted a total of 293,500 , 213,576 and 64,676 shares of restricted stock or shares issuable pursuant to promises to issue shares of common stock during the years ended September 30, 2015, 2014, and 2013 , respectively. The stock granted during the year ended September 30, 2015 includes rights to receive a total of 83,000 shares, or at a holder’s election cash based on the fair market value of the shares, contingent on continued employment or service. The fair value of the awards granted was approximately $ 499,000 , $ 1,665,000 and $ 471,000 for the years ended September 30, 2015, 2014, and 2013 , respectively. All such shares of restricted stock vest and all such shares must be issued pursuant to the vesting period noted, provided the grantee has not voluntarily terminated service or been terminated for cause prior to the vesting or issuance date. There were 58,250 , 250 and 7,000 shares of restricted stock forfeited during the years ended September 30, 2015, 2014, and 2013 , respectively. The Company recognized the fair value of the restricted stock or promises to issue shares of common stock that vested during the fiscal year as share-based compensation expense of approximately $ 437,000 , $ 859,000 and $ 728,000 for the years ended September 30, 2015, 2014, and 2013 , respectively, $ 23,000 , $ 256,000 and $ 227,000 of which was included in accrued expenses at year end since the related shares have not yet been issued at September 30, 2015, 2014, and 2013 , respectively. For the year ended September 30, 2015 , the Company issued a portion of the executive bonus in stock for a total share-based compensation expense of approximately $53,000 . The share-based compensation expense was included in selling, general and administrative expenses for the respective periods. The Company recorded a tax benefit for stock-based compensation expenses of approximately $ 114,000 , $ 204,000 and $0 for the years ended September 30, 2015, 2014, and 2013 , respectively. The Company realized the tax benefit for stock-based compensation expenses, for the shares which vested, of approximately $190,000 , $0 and $0 for the years ended September 30, 2015, 2014, and 2013 , respectively. As of September 30, 2015 , there was approximately $ 655,000 , representing approximately 284,000 unvested shares, of total unrecognized compensation cost related to non-vested restricted stock compensation arrangements granted under the incentive plans. This unrecognized cost will be recognized over the weighted average period of the next 2.64 years. Common Stock Purchase Warrants The Company did not issue any common stock purchase warrants in fiscal year 2015 , 2014, or 2013 . In fiscal year 2013, a warrant holder exercised 52,000 warrants using the cashless exercise option available within the warrant agreements which entitled the warrant holder to 43,465 shares of common stock. There is no unrecognized compensation cost related to warrants as of September 30, 2015 . At September 30, 2015 and 201 4 , there were no outstanding warrants. Preferred Stock The Company has 5,000,000 shares designated as Class A Preferred Stock with a par value of $.01 per share. There are 1,040,000 shares of Class A Preferred Stock - Series 1 authorized; 1,500,000 shares of Class A Preferred Stock- Series 2 authorized; and 700,000 shares of Class A Preferred Stock - Series 3 authorized. There were no shares of Class A Preferred Stock of any series issued and outstanding in fiscal 2015 or 2014 . T he Company has 15,000 shares designated as Class B Preferred Stock with a par value of $.50 per share . There were no shares of Class B Preferred Stock issued and outstanding in fiscal 2015 or 2014 .

Stock Repurchase Program

Stock Repurchase Program	12 Months Ended
	Sep. 30, 2015
Stock Repurchase Program [Abstract]
Stock Repurchase Program	Note 8. Stock Repurchase Program The Company’s Stock Repurchase Program was announced on January 17, 2007. At initiation, the plan’s terms specified that up to 1,000,000 shares of its common stock could be purchased during the subsequent twelve months. Subsequently, the Board has amended the plan a number of times to both extend its term and increase the maximum number of shares which could be repurchased. Currently, the plan allows for a maximum repurchase of up to 3,000,000 shares through the period ending December 31, 201 5 . From the program’s onset through September 30, 2015 , the total number of shares repurchased by the Company is 2,183,704 . The Stock Repurchase Program authorizes purchases in privately negotiated transactions as well as in the open market. In October 2008, the Company's Board of Directors authorized repurchases in private transactions under the Stock Repurchase Program of shares issued under the Company's equity compensation plans to directors, employees and other service providers at the market price on the effective date of the repurchase request. Total repurchases under this provision currently are limited to an aggregate of 450,000 shares per calendar year and to a maximum of 50,000 shares annually per individual. Total repurchase transaction are as follows (in shares): 2015 2014 2013 Open market repurchase transactions - Private repurchase transactions Total repurchase transactions Total repurchase activity is as follows: Issuer Purchases of Equity Securities: Details of Treasury Stock Purchases to Date through September 30, 2015: Total Average Aggregate Number Maximum Number Number Price Paid of Shares Purchased of Shares that May of Shares Per As Part of Publicly Yet be Purchased Period Purchased Share Announced Program Under the Program January 1, 2007 – September 30, 2012 $ October 1, 2012 – September 30, 2013 October 1, 2013 – September 30, 2014 October 1, 2014 – September 30, 2015 Total $

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Sep. 30, 2015
Employee Benefit Plan [Abstract]
Employee Benefit Plan	Note 9. Employee Benefit Plan The Company has a Simple Individual Retirement Account (IRA) plan for its employees. Employees are eligible to participate in the plan if their compensation reaches certain minimum levels and are allowed to contribute up to a maximum of $15,500 annual compensation to the plan. The Company has elected to match 100 percent of employee contributions to the plan up to a maximum of 3 percent of employee compensation for the years ended September 30, 2015, 2014, and 2013 . Annual Company contributions were approximately $37,000 , $31,000 , and $29,000 for the years ended September 30, 2015, 2014, and 2013 , respectively. In March 2014, the Company elected to contribute 3 percent into the personal pension schemes of certain senior U.K. employees. Contributions for the years ended September 30, 2015 and 2014 were approximately $26,000 and $6,000 , respectively. Pension contributions were not made for the certain senior U.K. employees for the year ended September 30, 2013 .

Industry Segments And Financial

Industry Segments And Financial Information About Foreign And Domestic Operations	12 Months Ended
	Sep. 30, 2015
Industry Segments And Financial Information About Foreign And Domestic Operations [Abstract]
Industry Segments And Financial Information About Foreign And Domestic Operations	Note 10. Industry Segments and Financial Information about Foreign and Domestic Operations The Company currently operates in one industry segment which includes the development, manufacture and marketing of consumer health care products. The Company operates in foreign and domestic regions. Information about the Company's operations by geographic area is as follows (in thousands). Net Revenues to External Customers for Long-Lived Asset As Of the Year Ended September 30, September 30, 2015 2014 2013 2015 2014 Brazil $ (1) $ * $ (1) $ - $ - Zimbabwe * - - South Africa (1) (1) - - United States Angola * (1) * - - DR of Congo * - - Tanzania * * - - Nigeria * * - - Uganda * * - - Malaysia * * * United Kingdom * * * Other - - Total $ $ $ $ $ * Less than 5 percent of total net revenues. (1) Exceeds 10 percent of total net revenues.

Contingent Liabilities

Contingent Liabilities	12 Months Ended
	Sep. 30, 2015
Contingent Liabilities [Abstract]
Contingent Liabilities	Note 11. Contingent Liabilities The testing, manufacturing and marketing of consumer products by the Company entail an inherent risk that product liability claims will be asserted against the Company. The Company maintains product liability insurance coverage for claims arising from the use of its products. The coverage amount is currently $ 10 million for FHC's consumer health care product.

Dividends

Dividends	12 Months Ended
	Sep. 30, 2015
Dividends [Abstract]
Dividends	Note 1 2 . Dividends Beginning February 16, 2010 through May 7, 2014, the Company paid 18 quarterly cash dividends. The first 9 were paid at a quarterly rate per share of $0.05 through February 9, 2012, 4 were paid at a quarterly rate per share of $0.06 from May 9, 2012 through February 6, 2013, and 5 were paid at a quarterly rate per share of $0.07 from May 8, 2013 through May 7, 2014. C ash dividends paid totaled $29.4 million through September 30, 2014. T he Company paid cash dividends of approximately $6.1 million and $7.5 million in 2014 and 2013, respectively. On July 14, 2014, the Company announced that its Board of Directors elected to suspend the payment of quarterly cash dividends in order to devote operating cash flows towards strategic growth initiatives.

Quarterly Financial Data

Quarterly Financial Data	12 Months Ended
	Sep. 30, 2015
Quarterly Financial Data [Abstract]
Quarterly Financial Data	Note 1 3 . Quarterly Financial Data (Unaudited) First Second Third Fourth Year Quarter Quarter Quarter Quarter Ended 2015 Net revenues $ $ $ $ $ Gross profit Operating expenses Income tax expense Net income Net income per common share – basic Net income per common share – diluted 2014 Net revenues $ $ $ $ $ Gross profit Operating expenses Income tax expense Net income (loss) Net income (loss) per common share – basic Net income (loss) per common share – diluted

Nature of Business and Signif21

Nature of Business and Significant Accounting Policies (Policy)	12 Months Ended
	Sep. 30, 2015
Nature of Business and Significant Accounting Policies [Abstract]
Principles Of Consolidation And Nature Of Operations	Principles of consolidation and nature of operations : The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, The Female Health Company – UK, and its wholly owned subsidiaries, The Female Health Company - UK, plc and The Female Health Company (M) SDN.BHD. All significant intercompany transactions and accounts have been eliminated in consolidati on. The Female Health Company ( FHC or the Company) is currently engaged in the marketing, manufacture and distribution of a consumer health care product, the FC2 female condom ( FC2). The Female Health Company - UK, is the holding company of The Female Health Company - UK, plc, which is located in a 6,400 sq. ft. leased office facility located in London, England (collectively the U.K. subsidiary) . The Female Health Company (M) SDN.BHD leases a 45,800 sq. ft. manufacturing facility located in Selangor D.E., Malaysia (the Malaysia subsidiary) . FC2 has been distributed in either or both commercial (private sector) and public health sector markets in 144 countries. It is marketed to consumers through distributors, public health programs and retailers in 16 countries. The Company's standard credit terms vary from 30 to 120 days, depending on the class of trade and customary terms within a territory, so accounts receivable is affected by the mix of purchasers within the period. As is typical in the Company's business, extended credit terms may occasionally be offered as a sales promotion or for certain sales . The Company has agreed to credit terms of up to 150 days with our distributor in the Republic of South Africa. For the most recent order of 15 million units under the Brazil tender, the Company has agreed to up to 360 day credit terms with our distributor in Brazil subject to earlier payment upon receipt of payment by the distributor from the Brazilian Government. For the past twelve months, the Company's average days’ sales outstanding was approximately 131 days. Over the past five years, the Company’s bad debt expense has been less than 0.03 percent of product sales.
Restricted Cash	Restricted cash : Restricted cash relates to security provided to one of the Company’s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of $250,000 for such performance bonds. Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provi der of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiratio n of the product shelf life. Restricted cash was $85,697 and $55,806 for the years ended September 30, 2015 and 2014 , respectively, and is included in cash on the accompanying balance sheets.
Use Of Estimates	Use of estimates : The preparation of financial statements requires management to make estimates and use assumptions that affect certain reported amounts and disclosures. Significant accounting estimates include the deferred income tax valuation allowance and the value of share -based compensation. Actual results may differ from those estimates.
Cash Concentration	Cash concentration : The Company’s cash is maintained primarily in three financial institutions, located in Clayton, Missouri, London, England and Kuala Lumpur, Malaysia , respectively .
Accounts Receivable And Concentration Of Credit Risk	Accounts receivable and concentration of credit risk : Accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a periodic basis. The components of accounts receivable consist of the following at September 30, 2015 and 2014 : 2015 2014 Trade receivables $ $ Other receivables Accounts receivable, gross Less: allowance for doubtful accounts Accounts receivable, net $ $ The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments on accounts receivable. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Management also periodically evaluates individual customer receivables and considers a customer’s financial condition, credit history, and the current economic conditions. Accounts receivable are written-off when deemed uncollectible. The table below sets forth the components of the allowance for doubtful accounts for the years ended September 30: Balance at Provision Charges Write offs/ Balance at Year October 1 to Expenses Recoveries September 30 2013 $ $ $ $ 2014 $ $ $ $ 2015 $ $ — $ — $ Recoveries of accounts receivable previously written-off are recorded when received. The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other governmental agencies which purchase and distribute the female condom for use in HIV/AIDS prevention and family planning programs. In fiscal year 201 5 , our significant customers were Sem ina Indústria e Comércio Ltda ( Semina), U nited Nations Population Fund ( UNFPA), and John Snow, Inc., facilitat or of USAID I DELIVER project ( USAID) . In fiscal year 2014, our significant customers were UNFPA, USAID, Sekunjalo Inve stments Corporation (PTY) Ltd ( Sekunjalo) , and Azinor International Lda ( Azinor). In fiscal year 2013, our significant customer was UNFPA. No other single customer accounted for more than 10 percent of unit sales during those periods. Percentage of Unit Sales Significant Customers 2015 2014 2013 Semina * * UNFPA USAID * Sekunjalo * * Azinor * * Total Percentage of Unit Sales _____________________ * Less than 10 percent of unit sales. Semina’s accounts receivable balance represented 46 percent of current assets at September 30, 2015 and UNFPA’s accounts receivable balance represented 12 percent of current assets at September 30, 2014. No other single customer’s accounts receivable balance accounted for more than 10 percent of current assets at the end of those periods.
Inventory	Inventory : Inventories are valued at the lower of cost or market. The cost is determined using the first-in, first-out (FIFO) method. Inventories are also written down for management’s estimates of product which will not sell prior to its expiration date. Write-downs of inventories establish a new cost basis which is not increased for future increases in the market value of inventories or changes in estimated obsolescence.
Foreign Currency Translation and Operations	Foreign currency translation and operations : Effective October 1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries’ functional currency. The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries. Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company’s first generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October 1, 2009. As the Malaysia subsid iary is a direct and integral component of the U.K. parent’s operations, it, too, adopted the U.S. dollar as its functional currency as of October 1, 2009. The consistent use of the U.S. dollar as functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The Company recognized a foreign currency transaction gain of $ 58,483 and a foreign currency transaction loss of $ 83,844 and $ 101,288 for the years ended September 30, 2015, 2014, and 2013 , respectively. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was $581,519 as of September 30, 2015 and 2014 . Assets located outside of the U.S. totaled approximately $10,000,000 and $12,000,000 at September 30, 2015 and 2014 , respectively.
Equipment, Furniture And Fixtures	Equipment, furniture and fixtures : Depreciation and amortization are computed using primarily the straight-line method. Depreciation and amortization are computed over the estimated useful lives of the respective assets which range as follows: Manufacturing equipment 5 – 10 years Office equipment 3 years Furniture and fixtures 7 – 10 years Depreciation on leased assets is computed over the lesser of the remaining lease term or the estimated useful lives of the assets. Depreciation on leased assets is included with depreciation on owned assets.
Patents And Trademarks	Patents and trademarks : The costs for patents and trademarks are expensed when incurred. FC2 patents have been issued by the United States, Europe, Canada, Australia, South Africa, the People’s Republic of China, Japan, Mexico, Brazil, India and the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, Gambia, Ghana , Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone, Sudan, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. Further, the European patent for FC2 has been validated in the following countries: Austria, Belgium, Bulgaria, Switzerland, Republic of Cyprus, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, United Kingdom, Greece, Hungary, Ireland, Italy, Luxembourg, Monaco, Netherlands, Portugal, Romania, Sweden, Slovenia, Slovakia, and Turkey. The patents cover the key aspects of FC2, including its overall design and manufacturing process. The patents have expiration dates in 2023 and 2024. In addition, patent applications for FC2 are pending in a number of other countries around the world. There can be no assurance that pending patent applications provide the Company with protection against copycat products entering markets during the pendency of the applications. The Company has a registration for the trademark “FC2 Female Condom” in the United States. Furthermore, the Company has filed applications or secured registrations in 39 countries or jurisdictions around the world to protect the various names and symbols used in marketing FC2. In addition, the experience that has been gained through years of manufacturing its Female Condoms (FC1 and FC2) has allowed the Company to develop trade secrets and know-how, including certain proprietary production technologies, that further protect its competitive position.
Financial Instruments	Financial instruments : The Company follows ASC Topic 820, Fair Value Measurements and Disclosures , which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The Company currently does not have any assets or liabilities measured at fair value on a recurring or non-recurring basis. Substantially all of the Company’s cash , as well as restricted cash , are held in demand deposits with three financial institutions. The Company has no financial instruments for which the carrying value is materially different than fair value.
Research And Development Costs	Research and development costs : Research and development costs are expensed as incurred. The amount of costs expensed for the years ended September 30, 2015, 2014, and 2013 were $219,815 , $5,575 , and $4,745 , respectively .
Revenue Recognition	Revenue recognition : The Company recognizes revenue from product sales when each of the following conditions has been met: an arrangement exists, delivery has occurred, there is a fixed price, and collectability is reasonably assured.
Share-based Compensation	Share-based compensation : The Company accounts for stock-based compensation expense for equity awards exchanged for services over the vesting period base d on the grant-date fair value. In many instances, the equity awards are issued upon the grant date subject to vesting periods. In certain instances, the equity awards provide for future issuance contingent on future continued employ ment or performance of services as of the issuance date.
Advertising	Advertising : The Company's policy is to expense advertising costs as incurred. Advertising costs were $ 0 , $ 58,121 , and $ 221,718 for the years ended September 30, 2015, 2014, and 2013 , respectively.
Income Taxes	Income taxes : The Company files separate income tax returns for its foreign subsidiaries. ASC Topic 740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized.
Earnings Per Share (EPS)	Earnings per share (EPS) : Basic EPS is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options and unvested shares granted to employees and directors.
Other Comprehensive Income	Other comprehensive income : Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net income. Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying consolidated balance sheets, these items, along with net income, are components of comprehensive income. The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company’s policy and intent is to settle the intercompany trade account on a current basis. Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October 1, 2009, no foreign currency gains or losses from intercompany trade are recognized. In fiscal 2015, 2014, and 2013 , comprehensive income is equivalent to the reported net income.
Reclassifications	Reclassifications: Certain items in the 2014 and 2013 consolidated financial statements have been reclassified to conform to the 2015 presentation.

Nature Of Business And Signif22

Nature Of Business And Significant Accounting Policies (Tables)	12 Months Ended
	Sep. 30, 2015
Nature of Business and Significant Accounting Policies [Abstract]
Components Of Accounts Receivable	2015 2014 Trade receivables $ $ Other receivables Accounts receivable, gross Less: allowance for doubtful accounts Accounts receivable, net $ $
Summary Of Components Of Allowance For Doubtful Accounts	Balance at Provision Charges Write offs/ Balance at Year October 1 to Expenses Recoveries September 30 2013 $ $ $ $ 2014 $ $ $ $ 2015 $ $ — $ — $
Summary Of Significant Customers	Percentage of Unit Sales Significant Customers 2015 2014 2013 Semina * * UNFPA USAID * Sekunjalo * * Azinor * * Total Percentage of Unit Sales _____________________ * Less than 10 percent of unit sales.
Summary Of Depreciation And Amortization	Manufacturing equipment 5 – 10 years Office equipment 3 years Furniture and fixtures 7 – 10 years

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Schedule Of Earnings Per Share, Basic And Diluted	Year Ended September 30, Denominator 2015 2014 2013 Weighted average common shares outstanding - basic Net effect of dilutive securities: Options Unvested restricted shares Total net effect of dilutive securities Weighted average common shares outstanding - diluted Income per common share – basic $ $ $ Income per common share – diluted $ $ $

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Sep. 30, 2015
Inventory [Abstract]
Components Of Inventory	2015 2014 Raw material $ $ Work in process Finished goods Inventory, gross Less: inventory reserves Inventory, net $ $
Change In Inventory Reserve	Balance at Charged to Costs Balance at Year October 1 and Expenses Write-offs September 30 2013 $ $ $ $ 2014 $ $ $ $ 2015 $ $ $ $

Operating Leases And Rental E25

Operating Leases And Rental Expense (Tables)	12 Months Ended
	Sep. 30, 2015
Operating Leases And Rental Expense [Abstract]
Schedule Of Operating Lease Expense, Including Real Estate Taxes And Insurance	2015 2014 2013 Factory and office leases $ $ $ Other Total $ $ $
Schedule Of Future Minimum Payments Under Leases	Operating Leases 2016 2017 2018 2019 2020 Total minimum lease payments $

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Sep. 30, 2015
Income Taxes [Abstract]
Schedule Of Income Before Income Taxes, By Jurisdictions	2015 2014 2013 Domestic $ $ $ Foreign Total $ $ $
Reconciliation Of Income Tax Expense	2015 2014 2013 Income tax expense at statutory rates $ $ $ State income tax, net of federal benefits Non-deductible expenses Effect of lower foreign income tax rates Effect of change in U.K. tax rate — — Effect of reinvestment allowance - Malaysia — Effect of export allowance - Malaysia — — Effect of change in Illinois tax rate — — Effect of conversion of charitable contribution to NOL — — Other — Change in valuation allowance Income tax expense (benefit) $ $ $
Summary Of Federal And State Income Tax Provision (Benefit)	2015 2014 2013 Deferred – U.S. $ $ $ Deferred – U.K. Deferred – Malaysia Subtotal Current – U.S. Current – Malaysia Current - U.K. — — Subtotal Income tax expense (benefit) $ $ $
Significant Components Of Deferred Tax Assets And Liabilities	Deferred Tax Assets 2015 2014 Federal net operating loss carryforwards $ $ State net operating loss carryforwards AMT credit carryforward Foreign net operating loss carryforwards – U.K. Foreign capital allowance – U.K. Other, net - Malaysia Share-based compensation Other, net - U.S. Gross deferred tax assets Valuation allowance for deferred tax assets Net deferred tax assets Deferred Tax Liabilities: Foreign capital allowance – Malaysia Net deferred tax assets $ $
Schedule Of Deferred Tax Amounts Classified In Balance Sheets	2015 2014 Current assets – U.S. $ $ Current assets – U.K. — Total current assets Long-term assets – U.S. Long-term assets – U.K Total long-term assets Long-term liability – Malaysia $ $
Changes In Valuation Allowance For Deferred Tax Assets	Balance at Charged to Costs Balance at Year October 1 and Expenses Deductions/Other September 30 2013 $ $ $ $ 2014 $ $ $ $ 2015 $ $ $ — $

Equity And Share-Based Paymen27

Equity And Share-Based Payments (Tables)	12 Months Ended
	Sep. 30, 2015
Equity And Share-Based Payments [Abstract]
Summary Of Stock Options Outstanding And Exercisable	Weighted Average Remaining Aggregate Exercise Price Contractual Term Intrinsic Shares Per Share (years) Value Outstanding at September 30, 2012 $ Granted — - Exercised Forfeited — - Outstanding at September 30, 2013 $ Granted — — Exercised Forfeited — — Outstanding at September 30, 2014 $ Granted — — Exercised — — Forfeited — — Outstanding at September 30, 2015 $ $ Exercisable on September 30, 2015 $ $
Summary Of Non-Vested Stock Activity	Weighted Average Grant -Date Shares Fair Value Vesting Period Total Outstanding September 30, 2012 $ Stock Granted September 2013 - May 2016 Vested Forfeited Total Outstanding September 30, 2013 $ Stock Granted September 2014 - December 2016 Vested Forfeited Total Outstanding September 30, 2014 $ Stock Granted September 2015 - August 2018 Vested Forfeited Total Outstanding September 30, 2015 $

Stock Repurchase Program (Table

Stock Repurchase Program (Tables)	12 Months Ended
	Sep. 30, 2015
Stock Repurchase Program [Abstract]
Total Repurchase Transactions	2015 2014 2013 Open market repurchase transactions - Private repurchase transactions Total repurchase transactions
Schedule Of Treasury Stock Purchases	Issuer Purchases of Equity Securities: Details of Treasury Stock Purchases to Date through September 30, 2015: Total Average Aggregate Number Maximum Number Number Price Paid of Shares Purchased of Shares that May of Shares Per As Part of Publicly Yet be Purchased Period Purchased Share Announced Program Under the Program January 1, 2007 – September 30, 2012 $ October 1, 2012 – September 30, 2013 October 1, 2013 – September 30, 2014 October 1, 2014 – September 30, 2015 Total $

Industry Segments And Financi29

Industry Segments And Financial Information About Foreign And Domestic Operations (Tables)	12 Months Ended
	Sep. 30, 2015
Industry Segments And Financial Information About Foreign And Domestic Operations [Abstract]
Schedule Of Operations By Geographic Area	Net Revenues to External Customers for Long-Lived Asset As Of the Year Ended September 30, September 30, 2015 2014 2013 2015 2014 Brazil $ (1) $ * $ (1) $ - $ - Zimbabwe * - - South Africa (1) (1) - - United States Angola * (1) * - - DR of Congo * - - Tanzania * * - - Nigeria * * - - Uganda * * - - Malaysia * * * United Kingdom * * * Other - - Total $ $ $ $ $ * Less than 5 percent of total net revenues. (1) Exceeds 10 percent of total net revenues.

Quarterly Financial Data (Table

Quarterly Financial Data (Tables)	12 Months Ended
	Sep. 30, 2015
Quarterly Financial Data [Abstract]
Schedule Of Quarterly Financial Data	First Second Third Fourth Year Quarter Quarter Quarter Quarter Ended 2015 Net revenues $ $ $ $ $ Gross profit Operating expenses Income tax expense Net income Net income per common share – basic Net income per common share – diluted 2014 Net revenues $ $ $ $ $ Gross profit Operating expenses Income tax expense Net income (loss) Net income (loss) per common share – basic Net income (loss) per common share – diluted

Nature of Business and Signif31

Nature of Business and Significant Accounting Policies (Details)	12 Months Ended
	Sep. 30, 2015USD ($)ft²itemcountry	Sep. 30, 2014USD ($)	Sep. 30, 2013USD ($)
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Number of countries in which entity operates | country	144
Number of Countries that have filed applications or secured registrations | country	39
Number of Primary Financial Institutions Where Cash is Maintained | item	3
Average days sales outstanding	131 days
Period of which bad debts expense has been a certain percentage of sales	5 years
Advertising	$ 0	$ 58,121	$ 221,718
Restricted cash and cash equivalents, current	85,697	55,806
Foreign currency transaction gain (loss), realized	58,483	(83,844)	(101,288)
Other comprehensive income (loss), foreign currency transaction and translation gain (loss) arising during period, net of tax	(581,519)	(581,519)
Research and development expense	219,815	5,575	$ 4,745
Performance Bond [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Restricted cash and cash equivalents, current	250,000
Outside United States [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Other assets	$ 10,000,000	$ 12,000,000
London, England [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Area of real estate property (in square feet) | ft²	6,400
Selangor D.E., Malaysia [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Area of real estate property (in square feet) | ft²	45,800
South Africa [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Credit terms	150 days
Brazil [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Number of units ordered | item	15,000,000
Credit terms	360 days
Office Space [Member] | London, England [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Area of real estate property (in square feet) | ft²	6,400
Manufacturing Space [Member] | Selangor D.E., Malaysia [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Area of real estate property (in square feet) | ft²	45,800
Minimum [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Credit terms	30 days
Maximum [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Credit terms	120 days
Bad debt expense, percentage	0.03%
Country Specific Commercial Partners [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Number of countries in which entity marketed directly to consumers | country	16
Intercompany Trade Accounts [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Foreign currency transaction gain (loss), realized	$ 0

Nature Of Business And Signif32

Nature Of Business And Significant Accounting Policies (Components Of Accounts Receivable) (Details) - USD ($)	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 14,136,458	$ 2,991,918
Less: allowance for doubtful accounts	(48,068)	(48,068)	$ (13,180)	$ (41,625)
Accounts receivable, net	14,088,390	2,943,850
Trade Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	13,975,905	2,814,558
Other Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 160,553	$ 177,360

Nature Of Business And Signif33

Nature Of Business And Significant Accounting Policies (Summary Of Components Of Allowance For Doubtful Accounts) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Nature of Business and Significant Accounting Policies [Abstract]
Balance at October 1	$ 13,180	$ 41,625
Provision Charges to Expenses	38,068	3,180
Write offs/Recoveries	(3,180)	(31,625)
Balance at September 30	$ 48,068	$ 13,180

Nature Of Business And Signif34

Nature Of Business And Significant Accounting Policies (Summary Of Significant Customers) (Details)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014		Sep. 30, 2013
Total Revenue [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	81.00%	81.00%		62.00%
Total Revenue [Member] | Semina [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	47.00%		[1]		[1]
Total Revenue [Member] | UNFPA [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	18.00%	40.00%		62.00%	[1]
Total Revenue [Member] | USAID [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	16.00%	17.00%			[1]
Total Revenue [Member] | Sekunjalo Investments Corp [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		13.00%			[1]
Total Revenue [Member] | Azinor International Lda [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		11.00%			[1]
Total Revenue [Member] | Less Than 10 Percent Of Unit Sales [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	10.00%
Current Assets [Member] | Semina [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	46.00%
Current Assets [Member] | UNFPA [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		12.00%
Current Assets [Member] | More than 10 Percent of Unit Sales [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	10.00%	10.00%
[1]	Less than 10 percent of unit sales.

Nature Of Business And Signif35

Nature Of Business And Significant Accounting Policies (Summary Of Depreciation And Amortization) (Details)	12 Months Ended
	Sep. 30, 2015
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	3 years
Minimum [Member] | Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Minimum [Member] | Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Useful lives	7 years
Maximum [Member] | Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	10 years
Maximum [Member] | Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Useful lives	10 years

Earnings Per Share (Details)

Earnings Per Share (Details) - $ / shares	3 Months Ended								12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Schedule of Earnings Per Share, Basic and Diluted [Line Items]
Weighted average common shares outstanding - basic									28,532,327	28,522,525	28,376,607
Net effect of dilutive securities									384,721	342,859	349,871
Weighted average common shares outstanding - diluted									28,917,048	28,865,384	28,726,478
Income per common share – basic (in Dollars per share)	$ 0.02	$ 0.04	$ 0.06	$ 0.03	$ (0.02)	$ 0.04	$ 0.01	$ 0.05	$ 0.15	$ 0.09	$ 0.51
Income per common share – diluted (in Dollars per share)	0.02	$ 0.04	$ 0.06	$ 0.03	(0.02)	$ 0.04	$ 0.01	$ 0.05	0.15	0.08	0.50
Exercise price of options outstanding not included in computation of diluted shares (in Dollars per share)	2.60				$ 2.60				$ 2.60	$ 2.60	$ 2.64	$ 2.57
Options [Member]
Schedule of Earnings Per Share, Basic and Diluted [Line Items]
Net effect of dilutive securities									50,473	109,583	162,195
anti-dilutive shares									90,000
Exercise price of options outstanding not included in computation of diluted shares (in Dollars per share)	$ 3.92								$ 3.92
Restricted Stock [Member]
Schedule of Earnings Per Share, Basic and Diluted [Line Items]
Net effect of dilutive securities									334,248	233,276	187,676

Inventory (Components Of Invent

Inventory (Components Of Inventory) (Details) - USD ($)	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Inventory [Abstract]
Raw material	$ 839,179	$ 1,091,703
Work in process	77,483	15,962
Finished goods	868,270	1,936,655
Inventory, gross	1,784,932	3,044,320
Less: inventory reserves	(39,752)	(60,873)	$ (41,133)	$ (49,810)
Inventory, net	$ 1,745,180	$ 2,983,447

Inventory (Change In Inventory

Inventory (Change In Inventory Reserve) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Inventory [Abstract]
Balance at October 1	$ 60,873	$ 41,133	$ 49,810
Charged to costs and expenses	173,634	37,603	(6,662)
Write-offs	(194,755)	(17,863)	(2,015)
Balance at September 30	$ 39,752	$ 60,873	$ 41,133

Revolving Line Of Credit (Detai

Revolving Line Of Credit (Details) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity (in Dollars)	$ 2,000,000
Line of Credit Facility, Amount Outstanding	$ 0	$ 0
Ratio of total liabilities to total stockholders equity	100
Line of credit facility, interest rate at period end	3.25%
Inventory [Member]
Line of Credit Facility [Line Items]
Line of credit facility, percentage of assets borrowing	50.00%
Minimum [Member] | Accounts Receivable [Member]
Line of Credit Facility [Line Items]
Line of credit facility, percentage of assets borrowing	70.00%
Maximum [Member] | Accounts Receivable [Member]
Line of Credit Facility [Line Items]
Line of credit facility, percentage of assets borrowing	80.00%

Operating Leases And Rental E40

Operating Leases And Rental Expense (Narrative) (Details)	Nov. 01, 2011	Nov. 01, 2010	Sep. 30, 2015USD ($)ft²	Dec. 31, 2011USD ($)	Jun. 30, 2015USD ($)
Equipment [Member]
Operating Leased Assets [Line Items]
Operating lease monthly payments			$ 616
Chicago, Illinois [Member] | Office Space [Member]
Operating Leased Assets [Line Items]
Area of real estate property (in square feet) | ft²			5,100
Operating lease term	5 years
Operating lease abatement tem		5 months
Extension of term of lease			3 years
Chicago, Illinois [Member] | Minimum [Member] | Office Space [Member]
Operating Leased Assets [Line Items]
Operating leases escalating monthly payments			$ 6,797
Chicago, Illinois [Member] | Maximum [Member] | Office Space [Member]
Operating Leased Assets [Line Items]
Operating leases escalating monthly payments			$ 7,859
London, England [Member]
Operating Leased Assets [Line Items]
Area of real estate property (in square feet) | ft²			6,400
London, England [Member] | Office Space [Member]
Operating Leased Assets [Line Items]
Area of real estate property (in square feet) | ft²			6,400
Operating lease term			5 years
Operating lease quarterly rental payments			$ 27,000	$ 13,500	$ 27,000
Security deposit			$ 67,000
Selangor D.E., Malaysia [Member]
Operating Leased Assets [Line Items]
Area of real estate property (in square feet) | ft²			45,800
Selangor D.E., Malaysia [Member] | Manufacturing Space [Member]
Operating Leased Assets [Line Items]
Area of real estate property (in square feet) | ft²			45,800
Operating lease renewal term			3 years
Operating lease monthly payments			$ 13,000

Operating Leases And Rental E41

Operating Leases And Rental Expense (Schedule Of Operating Lease Expense, Including Real Estate Taxes And Insurance) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Operating Leased Assets [Line Items]
Operating lease expense	$ 477,436	$ 444,480	$ 410,219
Factory and Office Leases [Member]
Operating Leased Assets [Line Items]
Operating lease expense	470,049	439,722	404,678
Other [Member]
Operating Leased Assets [Line Items]
Operating lease expense	$ 7,387	$ 4,758	$ 5,541

Operating Leases And Rental E42

Operating Leases And Rental Expense (Schedule Of Future Minimum Payments Under Leases) (Details)	Sep. 30, 2015USD ($)
Operating Leases And Rental Expense [Abstract]
2,016	$ 371,528
2,017	131,032
2,018	123,002
2,019	122,491
2,020	91,919
Total minimum lease payments	$ 839,972

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Income Tax Expense (Benefit) [Line Items]
Valuation allowance, deferred tax asset, change in amount	$ 16,000	$ 444,000	$ 10,453,000
Unrecognized tax benefits	0	0
Expense for interest and penalties related to uncertain tax positions	0	$ 0	$ 0
Federal [Member]
Income Tax Expense (Benefit) [Line Items]
Operating loss carryforwards	13,023,000
State [Member]
Income Tax Expense (Benefit) [Line Items]
Operating loss carryforwards	$ 12,587,000
U.S. [Member]
Income Tax Expense (Benefit) [Line Items]
Audit tax period	3 years
U.K. [Member]
Income Tax Expense (Benefit) [Line Items]
Operating loss carryforwards	$ 61,938,000
Audit tax period	1 year
Filing date or deadline period after end of accounting period	1 year
Malaysia [Member]
Income Tax Expense (Benefit) [Line Items]
Audit tax period	5 years
Filing date or deadline period after end of accounting period	7 months

Income Taxes (Schedule Of Incom

Income Taxes (Schedule Of Income Before Income Taxes, By Jurisdictions) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Income Taxes [Abstract]
Domestic	$ 4,524,499	$ 2,837,835	$ 7,461,329
Foreign	2,162,541	1,119,356	2,472,525
Income before income taxes	$ 6,687,040	$ 3,957,191	$ 9,933,854

Income Taxes (Reconciliation Of

Income Taxes (Reconciliation Of Income Tax Expense) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Income Tax Expense (Benefit) [Line Items]
Income tax expense at statutory rates									$ 2,274,000	$ 1,345,000	$ 3,378,000
State income tax, net of federal benefits									362,000	248,000	623,000
Non-deductible expenses									51,000	(5,000)	129,000
Effect of lower foreign income tax rates									(351,244)	(175,632)	(395,441)
Effect of reinvestment allowance - Malaysia										(9,000)	(75,000)
Effect of export allowance - Malaysia									(85,000)
Effect of conversion of charitable contribution to NOL									(36,174)
Other									(59,578)	56,762
Change in valuation allowance									(16,000)	64,000	(7,909,303)
Income tax expense (benefit)	$ 79,229	$ 284,900	$ 1,306,445	$ 670,430	$ 69,036	$ 851,321	$ 504,898	$ 98,875	2,341,004	$ 1,524,130	(4,408,744)
U.K. [Member]
Income Tax Expense (Benefit) [Line Items]
Effect of change in tax rate											$ (159,000)
Illinois [Member]
Income Tax Expense (Benefit) [Line Items]
Effect of change in tax rate									$ 202,000

Income Taxes (Summary Of Federa

Income Taxes (Summary Of Federal And State Income Tax Provision (Benefit)) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Components of Income Tax Expense (Benefit) [Line Items]
Subtotal - Deferred									$ 1,925,739	$ 1,012,334	$ (5,259,065)
Subtotal - Current									415,265	511,796	850,321
Income tax expense (benefit)	$ 79,229	$ 284,900	$ 1,306,445	$ 670,430	$ 69,036	$ 851,321	$ 504,898	$ 98,875	2,341,004	1,524,130	(4,408,744)
U.S. [Member]
Components of Income Tax Expense (Benefit) [Line Items]
Deferred - Federal									1,856,000	561,000	(12,000)
Current - Federal									83,606	219,000	625,606
U.K. [Member]
Components of Income Tax Expense (Benefit) [Line Items]
Deferred - Foreign									162,000	496,000	(5,288,000)
Current - Foreign											3,090
Malaysia [Member]
Components of Income Tax Expense (Benefit) [Line Items]
Deferred - Foreign									(92,261)	(44,666)	40,935
Current - Foreign									$ 331,659	$ 292,796	$ 221,625

Income Taxes (Significant Compo

Income Taxes (Significant Components Of Deferred Tax Assets And Liabilities) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Components Of Deferred Tax Assets And Liabilities [Line Items]
Federal net operating loss carryforwards	$ 4,428,000	$ 5,871,000
State net operating loss carryforwards	644,000	1,067,000
AMT credit carryforward	390,000	301,000
Foreign net operating loss carryforwards – U.K.	12,388,000	12,574,000
Foreign capital allowance – U.K.	114,000	110,000
Share-based compensation	128,000	204,000
Gross deferred tax assets	18,113,097	20,164,153
Valuation allowance for deferred tax assets	(2,575,000)	(2,591,000)
Net deferred tax assets	15,538,097	17,573,153
Deferred Tax Liabilities:
Foreign capital allowance – Malaysia	(111,349)	(220,666)
Net deferred tax assets	15,426,748	17,352,487
Malaysia [Member]
Components Of Deferred Tax Assets And Liabilities [Line Items]
Other, net	13,097	30,153
U.S. [Member]
Components Of Deferred Tax Assets And Liabilities [Line Items]
Other, net	$ 8,000	$ 7,000

Income Taxes (Schedule Of Defer

Income Taxes (Schedule Of Deferred Tax Amounts Classified In Balance Sheets) (Details) - USD ($)	Sep. 30, 2015	Sep. 30, 2014
Components Of Deferred Tax Assets And Liabilities [Line Items]
Current assets	$ 1,016,000	$ 711,000
Long-term assets	14,509,000	16,832,000
Long-term liability – Malaysia	(98,252)	(190,513)
Net deferred tax assets	15,426,748	17,352,487
U.S. [Member]
Components Of Deferred Tax Assets And Liabilities [Line Items]
Current assets	854,000	711,000
Long-term assets	4,740,000	6,739,000
U.K. [Member]
Components Of Deferred Tax Assets And Liabilities [Line Items]
Current assets	162,000
Long-term assets	$ 9,769,000	$ 10,093,000

Income Taxes (Changes In Valuat

Income Taxes (Changes In Valuation Allowance For Deferred Tax Assets) (Details) - Valuation Allowance of Deferred Tax Assets [Member] - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at October 1	$ 2,591,000	$ 2,147,000	$ 12,600,000
Charged to Costs and Expenses	(16,000)	432,000	(5,300,000)
Deductions/Other		12,000	(5,153,000)
Balance at September 30	$ 2,575,000	$ 2,591,000	$ 2,147,000

Equity And Share-Based Paymen50

Equity And Share-Based Payments (Narrative) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation (in Dollars)	$ 489,689	$ 858,615	$ 727,609
Issuance of common stock upon cashless exercise of options		16,963	28,172
Cashless options, exercises in period		30,000	36,250
Cash options, exercises in period		30,000
Proceeds from exercise of stock options		$ 117,600
Options, exercises in period, intrinsic value (in Dollars)	$ 0	$ 154,000	$ 272,000
Grants in period	293,500	213,576	64,676
Share price (in Dollars per share)	$ 1.58
Fair value of awards granted (in Dollars)	$ 499,000	$ 1,665,000	$ 471,000
Shares forfeited in period	58,250	250	7,000
Shares, Exercised	0	(60,000)	(36,250)
Unvested shares	283,722	141,435	33,502	93,818
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Preferred Class A [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	5,000,000
Preferred stock, par or stated value per share (in Dollars per share)	$ 0.01
Preferred stock, issued	0
Preferred stock, outstanding	0
Preferred Class A Series 1 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	1,040,000
Preferred Class A Series 2 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	1,500,000
Preferred Class A Series 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	700,000
Preferred Class B [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	15,000
Preferred stock, par or stated value per share (in Dollars per share)	$ 0.50
Preferred stock, issued	0
Preferred stock, outstanding	0
Cashless [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cashless options, exercises in period		30,000	36,250
Non-option equity instruments, exercised			52,000
Rights under Continued Employment or Service [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period	83,000
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense (in Dollars)	$ 0
Warrants issued during the period	0	0	0
Class of warrant or right, outstanding	0	0
Warrants [Member] | Cashless [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock upon cashless exercise of warrants (in Shares)			43,465
Non-option equity instruments, exercised			52,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation (in Dollars)	$ 0	$ 0	$ 0
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation (in Dollars)	437,000	859,000	728,000
Unrecognized compensation expense (in Dollars)	$ 655,000
Unvested shares	284,000
Unrecognized compensation expense, period for recognition	2 years 7 months 21 days
Accrued expenses from shares not yet issued	$ 23,000	256,000	227,000
Tax benefit of stock-based compensation expense	114,000	204,000	0
Tax expense for stock-based compensation expenses	190,000	$ 0	$ 0
Executive Bonus [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation (in Dollars)	$ 53,000
Minimum [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year
Award requisite service period	1 year
Maximum [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Award requisite service period	3 years
2008 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	2,000,000
Number of shares granted	1,287,885
Award expiration period	10 years
Award vesting period	3 years
2008 Stock Incentive Plan [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage per month	2.80%
2008 Stock Incentive Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	150,000
Grants in period	0	0	0
1997 Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant	0
Award expiration period	10 years
Award vesting period	3 years
Expiration date	Dec. 31, 2006
1997 Stock Option Plan [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage per month	2.80%

Equity And Share-Based Paymen51

Equity And Share-Based Payments (Summary Of Stock Options Outstanding And Exercisable) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Equity And Share-Based Payments [Abstract]
Shares, Outstanding at September 30	180,000	240,000	276,250
Shares, Exercised	0	(60,000)	(36,250)
Shares, Outstanding at September 30	180,000	180,000	240,000
Shares, Exercisable on September 30, 2015	180,000
Weighted Average Exercise Price Per Share, Outstanding (in Dollars per share)	$ 2.60	$ 2.64	$ 2.57
Weighted Average Exercise Price Per Share, Exercised (in Dollars per share)		2.79	2.05
Weighted Average Exercise Price Per Share, Outstanding (in Dollars per share)	2.60	$ 2.60	$ 2.64
Weighted Average Exercise Price Per Share, Exercisable on September 30, 2015 (in Dollars per share)	$ 2.60
Weighted Average Remaining Contractual Term, Outstanding at September 30, 2015 (years)	2 years 4 months 2 days
Weighted Average Remaining Contractual Term, Exercisable on September 30, 2015 (years)	2 years 4 months 2 days
Aggregate Intrinsic Value, Outstanding at September 30, 2015 (in Dollars)	$ 27,900
Aggregate Intrinsic Value, Exercisable on September 30, 2015 (in Dollars)	$ 27,900

Equity And Share-Based Paymen52

Equity And Share-Based Payments (Summary Of Non-Vested Stock Activity) (Details) - $ / shares	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Equity And Share-Based Payments [Abstract]
Total Outstanding Shares	141,435	33,502	93,818
Stock Granted	293,500	213,576	64,676
Vested	(92,963)	(105,393)	(117,992)
Forfeited	(58,250)	(250)	(7,000)
Total Outstanding Shares	283,722	141,435	33,502
Weighted Average Grant -Date Fair Value (in Dollars per share)	$ 7.30	$ 6.80	$ 5.59
Weighted Average Grant -Date Fair Value, Stock Granted (in Dollars per share)	1.70	7.80	7.29
Weighted Average Grant -Date Fair Value, Vested (in Dollars per share)	4.70	8.15	6.17
Weighted Average Grant -Date Fair Value, Forfeited (in Dollars per share)	7.36	9.68	5.80
Weighted Average Grant -Date Fair Value (in Dollars per share)	$ 2.31	$ 7.30	$ 6.80

Stock Repurchase Program (Narra

Stock Repurchase Program (Narrative) (Details) - shares	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2012	Jan. 17, 2007
Equity, Class of Treasury Stock [Line Items]
Number of shares authorized to be repurchased					1,000,000
Total number of shares repurchased	2,183,704	2,183,454	2,014,454	1,958,829
Maximum repurchases allowed under provision through calendar year	450,000
Maximum repurchases allowed under provision annually per individual	50,000
Maximum [Member]
Equity, Class of Treasury Stock [Line Items]
Number of shares authorized to be repurchased	3,000,000

Stock Repurchase Program (Total

Stock Repurchase Program (Total Repurchase Transactions) (Details) - shares	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Stock Repurchase Program [Abstract]
Open market repurchase transactions		165,000	10,000
Private repurchase transactions	250	4,000	45,625
Total repurchase transactions	250	169,000	55,625

Stock Repurchase Program (Sched

Stock Repurchase Program (Schedule Of Treasury Stock Purchase) (Details) - $ / shares	12 Months Ended			72 Months Ended	105 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2015
Stock Repurchase Program [Abstract]
Total Number of Shares Purchased	250	169,000	55,625	1,958,829	2,183,704
Average Price Paid Per Share (in Dollars per share)	$ 3.80	$ 4.37	$ 7.11	$ 3.41	$ 3.57
Aggregate Number of Shares Purchased as Part of Publicly Announced Program	2,183,704	2,183,454	2,014,454	1,958,829	2,183,704
Maximum Number of Shares that May Yet be Purchased Under the Program	816,296	816,546	985,546	1,041,171	816,296

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Defined Contribution Plan [Line Items]
Defined Benefit Plan, Contributions by Employer (in Dollars)		$ 37,000	$ 31,000	$ 29,000
United States Postretirement Benefit Plan of US Entity [Member]
Defined Contribution Plan [Line Items]
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount (in Dollars)		$ 15,500
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent		100.00%
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay		3.00%
United States Postretirement Benefit Plan of US Entity [Member] | U.K. [Member]
Defined Contribution Plan [Line Items]
Defined Benefit Plan, Contributions by Employer (in Dollars)		$ 26,000	$ 6,000
Foreign Postretirement Benefit Plan [Member] | U.K. [Member]
Defined Contribution Plan [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	3.00%

Industry Segments And Financi57

Industry Segments And Financial Information About Foreign And Domestic Operations (Details)

3 Months Ended

12 Months Ended

Sep. 30, 2015USD ($)

Jun. 30, 2015USD ($)

Mar. 31, 2015USD ($)

Dec. 31, 2014USD ($)

Sep. 30, 2014USD ($)

Jun. 30, 2014USD ($)

Mar. 31, 2014USD ($)

Dec. 31, 2013USD ($)

Sep. 30, 2015USD ($)segment

Sep. 30, 2014USD ($)

Sep. 30, 2013USD ($)

Revenues from External Customers and Long-Lived Assets [Line Items]

Number of reportable segments | segment

1

Revenue, Net

$ 7,154,985

$ 7,813,207

$ 10,977,467

$ 6,659,206

$ 5,554,113

$ 7,900,055

$ 4,346,223

$ 6,690,195

$ 32,604,865

$ 24,490,586

$ 31,456,778

Long-Lived Asset

1,377,000

1,768,000

1,377,000

$ 1,768,000

Brazil [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

[1]

14,841,000

[2]

$ 4,480,000

Zimbabwe [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

2,696,000

[1]

$ 2,064,000

[2]

[2]

South Africa [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

2,331,000

2,928,000

[1]

$ 5,421,000

[1]

U.S. [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

2,029,000

2,381,000

$ 2,611,000

[2]

Long-Lived Asset

123,000

88,000

$ 123,000

88,000

Angola [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

[2]

2,477,000

[1]

DR of Congo [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

[2]

2,185,000

$ 2,467,000

Tanzania [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

[2]

$ 1,936,000

[2]

Nigeria [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

[2]

$ 2,879,000

Uganda [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

[2]

[1],[2]

$ 2,997,000

[1]

Malaysia [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

[2]

Long-Lived Asset

1,134,000

1,528,000

$ 1,134,000

$ 1,528,000

U.K. [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

[2]

Long-Lived Asset

$ 120,000

$ 152,000

$ 120,000

$ 152,000

Other Countries [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net Revenues to External Customers

$ 10,708,000

$ 10,520,000

$ 10,602,000

Sales Less Than Five Percent [Member] | Total Revenue [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Concentration risk, percentage

5.00%

Sales Exceeding Ten Percent [Member] | Total Revenue [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Concentration risk, percentage

10.00%

[1]

Exceeds 10 percent of total net revenues.

[2]

Less than 5 percent of total net revenues.

Contingent Liabilities (Details

Contingent Liabilities (Details) $ in Millions	Sep. 30, 2015USD ($)
Contingent Liabilities [Abstract]
Loss contingency, range of possible loss, maximum	$ 10

Dividends (Details)

Dividends (Details) $ / shares in Units, $ in Millions	9 Months Ended	12 Months Ended				24 Months Ended
	Feb. 06, 2013item$ / shares	Sep. 30, 2015item	Sep. 30, 2014USD ($)	May. 07, 2014item$ / shares	Sep. 30, 2013USD ($)	Feb. 09, 2012item$ / shares
Dividends [Abstract]
Number of dividends paid | item	4	18		5		9
Dividends payable, amount per share (in Dollars per share) | $ / shares	$ 0.06			$ 0.07		$ 0.05
Cumulative dividends paid			$ 29.4
Payments of dividends			$ 6.1		$ 7.5

Quarterly Financial Data (Detai

Quarterly Financial Data (Details) - USD ($)	3 Months Ended								12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Quarterly Financial Data [Abstract]
Net revenues	$ 7,154,985	$ 7,813,207	$ 10,977,467	$ 6,659,206	$ 5,554,113	$ 7,900,055	$ 4,346,223	$ 6,690,195	$ 32,604,865	$ 24,490,586	$ 31,456,778
Gross profit	4,123,644	4,632,535	6,394,107	3,819,673	2,886,773	4,170,270	2,385,941	3,678,494	18,969,959	13,121,478	17,504,358
Operating expenses	3,362,327	3,178,687	3,444,714	2,365,824	3,369,350	2,142,640	1,590,718	2,094,858	12,351,552	9,197,566	7,714,761
Income tax expense (benefit)	79,229	284,900	1,306,445	670,430	69,036	851,321	504,898	98,875	2,341,004	1,524,130	(4,408,744)
Net income (loss)	$ 702,571	$ 1,170,974	$ 1,667,574	$ 804,917	$ (566,121)	$ 1,159,498	$ 375,081	$ 1,464,603	$ 4,346,036	$ 2,433,061	$ 14,342,598
Net income (loss) per common share - basic	$ 0.02	$ 0.04	$ 0.06	$ 0.03	$ (0.02)	$ 0.04	$ 0.01	$ 0.05	$ 0.15	$ 0.09	$ 0.51
Net income (loss) per common share - diluted	$ 0.02	$ 0.04	$ 0.06	$ 0.03	$ (0.02)	$ 0.04	$ 0.01	$ 0.05	$ 0.15	$ 0.08	$ 0.50